Position in NTRA
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$760,060
+$60,095 QoQ
Shares Held
2,800
-20.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#471
of 844 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Sava Infond d.o.o. holds $8,701,182 across 6 Diagnostics & Research names. NTRA ranks #4 (8.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IQV |
Iqvia Holdings Inc.
|
24,424 | $4,719,204 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
3,930 | $1,970,344 | |
| 3 | DHR |
Danaher Corp /De/
|
5,640 | $1,074,307 | |
| 4 | NTRA |
Natera, Inc.
This page
|
2,800 | $760,060 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
180 | $94,759 | |
| 6 | WAT |
Waters Corp /De/
|
220 | $82,508 |
All Filings in NTRA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $760,060 | 2,800 | Shares | Defined | 2026-07-16 | |
| 2026-03-31 | $699,965 | 3,500 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $801,815 | 3,500 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $643,880 | 4,000 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $675,760 | 4,000 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $565,640 | 4,000 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $633,200 | 4,000 | Shares | Sole | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||